Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ján Podhorec"'
Publikováno v:
Onkologie. 16:130-133
Autor:
Jiří Navrátil, Eva Michalová, Ján Podhorec, Bořivoj Vojtěšek, Štěpán Tuček, Roman Hrstka, Ondřej Bílek
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 31(Suppl 2)
Background Non-steroidal anti-inflammatory drugs (NSAID) represent a group of medicaments inhibiting cyclooxygenase (COX) enzyme, and, in parallel, these drugs show also analgesic, antipyretic and anti-inflammatory effects. Due to their efficiency, g
Autor:
Pavel Fabian, Andrea Jurečková, Jana Králová, Igor Kiss, Ján Podhorec, Ondrej Bilek, Rostislav Vyzula, B Robešová, Lucia Šikulíncová, M Svoboda, Radek Lakomý, Karel Veselý, D Adámková Krákorová, Jiří Tomášek, S Tuček, Jana Halámková
Publikováno v:
Klinicka onkologie. 26:42-46
Background Malignant melanoma is considered to be highly resistant to chemotherapy, radiotherapy, hormonotherapy and standard immunotherapy (interleukin 2, interferon alpha). Radical surgery in the early stages of the disease is still the most effici
Autor:
Ján, Podhorec, Roman, Hrstka, Ondřej, Bílek, Štěpán, Tuček, Jiří, Navrátil, Eva, Michalová, Bořivoj, Vojtěšek
Publikováno v:
Journal of the Czech & Slovak Societies for Oncology / Klinická Onkologie; 2018 Supplement2, Vol. 31, p2S77-81, 5p
Autor:
Andrea Martisova, Lucia Sommerova, Adam Krejci, Iveta Selingerova, Tamara Kolarova, Filip Zavadil Kokas, Milos Holanek, Jan Podhorec, Tomas Kazda, Roman Hrstka
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 18, p 10845 (2022)
The TGF-β signaling pathway is involved in numerous cellular processes, and its deregulation may result in cancer development. One of the key processes in tumor progression and metastasis is epithelial to mesenchymal transition (EMT), in which TGF-
Externí odkaz:
https://doaj.org/article/3180081033df4b7b973492ac34e9ebd2
Autor:
Ladislav Dušek, Jana Halámková, Jiri Tomasek, Zdenek Kala, Rostislav Vyzula, Vlastimil Válek, Dagmar Adámková Krákorová, Iveta Zimová, Ján Podhorec, Jiri Prasek, Igor Kiss, S Tuček
Publikováno v:
Journal of Clinical Oncology. 31:155-155
155 Background: The transarterial chemoembolization (TACE) and the radiofrequency ablation (RFA) are the keystones of interventional therapy of primary and secondary liver malignancies in oncology. A compromised liver function may be a relative contr
Autor:
Pavla Bouchalova, Jindrich Beranek, Petr Lapcik, David Potesil, Jan Podhorec, Alexandr Poprach, Pavel Bouchal
Publikováno v:
Biomedicines, Vol 9, Iss 9, p 1145 (2021)
Renal cell carcinoma (RCC) represents about 2–3% of all cancers with over 400,000 new cases per year. Sunitinib, a vascular endothelial growth factor tyrosine kinase receptor inhibitor, has been used mainly for first-line treatment of metastatic cl
Externí odkaz:
https://doaj.org/article/5f4a174c514e4526ab6fe5e567ad82ae